Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...

Piper Sandler analysts are cautioning investors about a potential correction in the S&P 500, despite recent highs. Their note highlights a weakening market that could lead to a significant pullback.

Fastly (NYSE:FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its price target on the content delivery company after it reported ...

Piper Sandler analysts selected 20 stocks that are "bottom-fishing" ideas. These stocks have had technical grade rankings of ...

In a recent note, Piper Sandler chief investment strategist Michael Kantrowitz responded "So what?" to other strategists' skepticism and calls for bearishness as S&P 500 (^GSPC) valuations climb ...

Piper Sandler analyst Alexander Goldfarb upgraded BXP (BXP) to Overweight from Neutral with a price target of $105, up from $78. The views and opinions expressed herein are the views and opinions ...

MINNEAPOLIS, July 25, 2024--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Robert Parker, Eric Van Dam and Kurt Haras as managing directors ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Kashy Harrison from Piper Sandler maintained a Buy rating ... The company was founded by Edward H. Fenster, Robert N. Kreamer and Lynn M. Jurich in January 2007 and ...

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm notes the company announced Q3 revenue of $505M finished ...